Charles Carroll Financial Partners, LLC Merck & Co., Inc. Transaction History

Charles Carroll Financial Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $54,305 - $59,190	500 Added 8.47%	6,406 $739,000
Q1 2023 May 08, 2023	BUY	$102.94 - $114.86 $56,617 - $63,173	550 Added 10.27%	5,906 $628,000
Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $262 - $336	3 Added 0.06%	5,356 $594,000
Q2 2022 Jul 27, 2022	BUY	$83.49 - $94.64 $446,921 - $506,607	5,353 New	5,353 $488,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Charles Carroll Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Charles Carroll Financial Partners, LLC with notifications on news.